Zobrazeno 1 - 10
of 50
pro vyhledávání: '"John A. Messenheimer"'
Autor:
Terence J, O'Brien, Samuel F, Berkovic, Jacqueline A, French, John A, Messenheimer, Terri B, Sebree, Marcel O, Bonn-Miller, Donna L, Gutterman, Fredrik, Asztely
Publikováno v:
JAMA network open. 5(7)
ImportanceCannabidiol has shown efficacy in randomized clinical trials for drug-resistant epilepsy in specific syndromes that predominantly affect children. However, high-level evidence for the efficacy and safety of cannabidiol in the most common fo
Publikováno v:
Therapeutic Drug Monitoring. 35:188-193
PURPOSE To assess the effect of common dosing irregularities on serum concentrations of antiepileptic drug (AED) lamotrigine for the extended-release (XR) formulation, which is recommended for once-daily dosing (QD), and the immediate-release (IR) fo
Autor:
Robert S. Greenwood, Michael B. Tennison, John A. Messenheimer, Stephen R. Quint, Bradley V. Vaughn
Publikováno v:
Journal of Epilepsy. 10:67-72
Analysis of heart period variability (HPV) is a valuable tool for the evaluation of autonomic influences over the cardiac cycle in patients at risk of sudden death. Using both time and frequency domain techniques, we analyzed the variation in heart p
Autor:
Kevin Robertson, K. N. Olivier, John A. Messenheimer, Bradley V. Vaughn, Thomas M. Egan, Rudy P. Lackner, I. I. Ali, Linda J. Paradowski
Publikováno v:
Epilepsia. 37:1175-1179
Summary: Purpose: We wished to assess organ transplant recipients, who incur a significant risk for seizures. Method: We reviewed 85 lung transplants performed in 81 patients at the University of North Carolina hospitals between 1991 and 1994. All pa
Publikováno v:
Journal of Epilepsy. 9:27-34
Seizures may prompt autonomically mediated changes in heart period. Heart period variability (HPV) is a sensitive tool for quantification of autonomic control over the cardiac cycle. We used analysis of HPV to evaluate changes in the time and frequen
Autor:
John A. Messenheimer
Publikováno v:
CNS Drug Reviews. 1:190-203
Autor:
Elizabeth L. Moore, Ilo E. Leppik, John A. Messenheimer, Marc E. Risner, Fumisuke Matsuo, Edward Faught, Steven C. Schachter
Publikováno v:
Journal of Epilepsy. 8:201-209
The safety of add-on lamotrigine (LTG, to 500 mg/day) was evaluated in 446 patients with partial seizures (334 LTG, 112 placebo) in a 6-month, multicenter, randomized, double-blind, parallel-group study. LTG had no clinically important effect on vita
Autor:
John A. Messenheimer
Publikováno v:
Clinical Neuropharmacology. 17:548-559
Autor:
John A. Messenheimer, Kim L. R. Brouwer, Karl H. Dorm, George E. Dukes, J. Robert Powell, Brenda D. Jamerson
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 14:47-52
Study Objective. To compare the frequency, severity, and time course of venous irritation after administration of a single intravenous dose of phenytoin with an equimolar dose of fosphenytoin, a water-soluble phenytoin prodrug. Design. Randomized, do
Publikováno v:
Sudden Death in Epilepsy: Forensic and Clinical Issues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e321fed3283ea8d012e1a6832a3febcd
https://doi.org/10.1201/b10317-33
https://doi.org/10.1201/b10317-33